Scientific communications organisation the Envision Pharma Group has revamped its top team, promoting David Thompson to chief executive officer as Brian Hepburn shifts to become its executi
Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity.
